More intensive LDL-C lowering may cut recurrent stroke risk
Feb 22, 2022
More intensive LDL-C-lowering with statin-based therapies was linked to a reduced risk for recurrent stroke for patients with evidence of atherosclerosis.
Model using routine clinical data may predict pancreatic cancer risk
Feb 14, 2022
The findings show promise following a diagnosis of impaired fasting glucose.
Two doses of mRNA-1273 effective against SARS-CoV-2 variants
Dec 15, 2021
Vaccine effectiveness against infection with delta variant declines with increasing time since vaccination.
Odds of SARS-CoV-2 infection down after third BNT162b2 dose
Dec 03, 2021
The estimated odds ratio of 0.14 at 28 to 65 days after receipt of the Pfizer-BioNTech booster was compared with those who received two doses.
Third BNT162b2 vaccine dose may cut severe COVID-19 outcomes
Nov 05, 2021
Fewer hospital admissions, cases of severe disease and COVID-19-related deaths were seen with the third dose of the Pfizer-BioNTech vaccine versus two doses received five months ago.
Allergy history may up risk for reactions to mRNA COVID-19 vaccine
Nov 04, 2021
The risk for allergic reactions within three days of vaccination is higher for those with history of high-risk allergy, but most completed the two-dose regimen. The mRNA vaccines approved for use against...
For fully vaccinated, immunity against SARS-CoV-2 wanes over time
Oct 29, 2021
The researchers found that among persons aged 60 years or older, the rate of infection was higher for those fully vaccinated in January 2021 (when they were first eligible) versus those fully vaccinated...
Higher dietary intake of alpha linolenic acid may lower mortality risk
Oct 15, 2021
Higher dietary intake of alpha linolenic acid through foods such as nuts, seeds and plant oils is linked to a reduced risk for mortality from all causes, cardiovascular disease and coronary heart disease.
Obesity may up length of stay, mortality for COVID-19 patients in ICU
Oct 14, 2021
A twofold higher risk for composite outcome of death or length of stay ≥14 days was seen in obese COVID-19 patients admitted to the ICU.
Booster dose of J&J COVID-19 vaccine may increase immunity
Sep 21, 2021
New research indicates two doses of the vaccine boosts immunity from 74 to 94%.